WE TRACK THOUSANDS OF POLITICIANS EACH AND EVERY DAY!

Their Biographies, Issue Positions, Voting Records, Public Statements, Ratings and their Funders.

S Amdt 2111 - Prohibits Pharmaceutical Companies from Delaying the Release of Generic Drugs - National Key Vote

Stage Details

Title: Prohibits Pharmaceutical Companies from Delaying the Release of Generic Drugs

See How Your Politicians Voted

Title: Prohibits Pharmaceutical Companies from Delaying the Release of Generic Drugs

Vote Smart's Synopsis:

Vote to adopt an amendment to S 3187 that authorizes generic drug manufacturers to file patents for and begin marketing generic drugs prior to the end of the 180-day exclusivity period.

Highlights:

  • Authorizes a “first applicant” to file a patent for a generic drug immediately if the applicant signs an agreement with the manufacturer of a listed drug, whereas existing law required an 180-day exclusivity period.
  • Defines “first applicant” as an individual who has lawfully filed a patent application for a drug biologically equivalent to a listed drug for which the patent is invalid or will not be infringed if the new drug is manufactured.
  • Specifies that the first applicant's patent will remain valid if action for patent infringement is not taken within 45 days or, if action is taken, a court dismisses the action for patent infringement.
  • Exempts drug makers who have signed an agreement with a generic drug manufacturer that prohibits the generic manufacturer from marketing the generic drug prior to the end of the 180-day exclusivity period from the provisions of this bill.

NOTE: THIS LEGISLATION NEEDED A TWO-THIRDS MAJORITY VOTE TO PASS

arrow_upward